This inventor holds 3 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 2003-2015.
Location History:
- København, DK (2003)
- København K, DK (2011)
- Kobenhavn K., DK (2015)
Company Filing History:
Years Active: 2003-2015
Title: Innovations by Anders Molin in Medical Technology
Introduction
Anders Molin is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of medical technology, particularly in the development of injection systems. With a total of 3 patents, his work focuses on enhancing the safety and efficiency of medical injections.
Latest Patents
Molin's latest patents include a disposable double point injection needle and an insulin injection system that incorporates this innovative needle design. The disposable double pointed injection needle features a needle hub that permanently fastens a thin needle cannula. This hub can be mounted onto a syringe equipped with a dose-setting and injection mechanism, along with a cartridge containing liquid medicine for subcutaneous injection. A key feature of this design is the safety shield, which is guided on the needle hub and is urged away from it by a spring. After an injection, the safety shield is automatically moved away from the needle hub and locked in a position that covers the needle cannula, thereby preventing accidental needle stick injuries.
Career Highlights
Anders Molin works at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His innovative designs have the potential to improve patient safety and comfort during medical procedures.
Collaborations
Molin collaborates with talented professionals in his field, including Lars Stenholt and Carsten Gerner Larsen. Their combined expertise contributes to the advancement of medical technologies.
Conclusion
Anders Molin's contributions to medical technology, particularly through his innovative injection systems, highlight the importance of safety in healthcare. His work continues to influence the industry and improve patient outcomes.
